Navigation Links
Alere Previews Findings from Key Research Study on Medication Adherence at Integrated Benefits Institute Conference
Date:3/1/2011

ATLANTA, March 1, 2011 /PRNewswire/ -- Medication adherence alone may not be enough to impact the productivity of employees with chronic conditions such as depression, diabetes, hypertension and coronary artery disease.  That key finding and others from a major research study will be previewed by Alere Health and other industry experts at the Integrated Benefits Institute (IBI) and National Business Coalition on Health (NBCH) Conference in San Francisco, Tuesday, March 1.

(Logo: http://photos.prnewswire.com/prnh/20100603/CL15025LOGO)

Alere Senior Healthcare Analyst Vince Haufle will co-present the overview along with other study authors.  Key participants in the study include Alere, IBI and the American College of Occupational and Environmental Medicine (ACOEM). Funding for the study was provided by the National Pharmaceutical Council (NPC).

The new study is a follow up to the landmark 2009 study, "Health and Productivity as a Business Strategy," which demonstrated how, on average, health-related lost productivity costs are 2.3 times more than the medical and pharmacy costs for chronic conditions. That same study also recommended a further look at the impact of medication adherence on lost productivity.

At the IBI presentation, Haufle and his co-presenters will give an overview of the research to be published, which was gathered over a 12-month period and covers five large employers with more than 86,000 employees.  The study looked at medication adherence, co-morbidity, health risks and other factors associated with workplace productivity.  Researchers were surprised to find that medication adherence alone did not always equate with higher levels of productivity.

"This study provides evidence suggesting that among a largely medication-compliant group of employees with chronic health conditions, high modifiable health risk status remained a significant predictor of lower job performance (presenteeism) and the number of chronic health condition co-morbidities a significant predictor of absence from work (absenteeism)," notes Haufle. "Medication adherence is obviously a critical element of an effective health management strategy to reduce illness burden.  However, this alone may be insufficient to reach the full potential for improving employee productivity.  The findings of this study underscore the importance of addressing elevated modifiable health risks in efforts to improve productivity.

"The takeaway for employers from this study is that you have to look at the whole patient – not just a single chronic illness," notes Haufle.  "We think that this study dramatically illustrates that even programs that promote medication adherence – which is without a doubt critical – must be sure to also address other illnesses the employee may have.  This approach will help employees be healthier, more productive on the job and ultimately reduce employers healthcare spend."

About Alere:

Alere Health is the health management services business of Alere Inc. (previously Inverness Medical Innovations) (NYSE: ALR).  Alere, a Latin verb, meaning "to care for" or "to support", offers the most patient-centered health management services available from a single provider in the industry. Alere provides health interventions that cover an individual's entire lifespan, from pre-cradle to end-of-life care, as well as the continuum from wellness and prevention, to total health management of the individual for those having chronic illnesses.  Alere's continuum of services begins with genetic testing, preconception, pregnancy, NICU and first year of life services; continues with lifelong programs focused on health, wellness and the management of chronic conditions such as heart failure, COPD, and asthma, up to the complex care management required in end-of-life care.  For more information regarding Alere, please visit www.alere.com.


'/>"/>
SOURCE Alere Health
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Alere Inc. Announces Fourth Quarter 2010 Results
2. Alere to Attend the Lazard Capital Markets 7th Annual Healthcare Conference on November 17, 2010
3. Alere to Attend the Fifth Annual JMP Securities Healthcare Conference on September 28, 2010
4. Alere Inc. Announces Pricing of Senior Subordinated Notes Offering; Offering Size Increased to $400.0 Million
5. Alere Inc. Announces Offering of $350 Million of Senior Subordinated Notes
6. Alere and AirStrip Technologies - a Powerful Collaboration Brings Innovative Remote Patient Monitoring to Obstetrical Care
7. Alere Inc. Schedules Conference Call for 10:00 a.m. ET July 28, 2010 to Discuss Second Quarter 2010 Results
8. Inverness Medical Innovations Changes Name to Alere
9. Misonix Previews New OsteoSculpt® Ultrasonic Bone Scalpel
10. Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology
11. Cancer Patients May Reduce Fast Growing Breast Cancer Recurrences: Findings Reported at 2010 San Antonio Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)...  Licenders is bringing their 100% all-natural lice removal service to ... at 203 13 th Street was specifically chosen to make ... "Our goal is to ease parents, stress and bring their ... children right back to class without skipping a beat. The best ... for the whole family," Licenders President Adie Horowitz states. ...
(Date:12/6/2016)... 6, 2016  "Blood Tests replace Surgical Biopsies. ... The Diagnostic, Monitoring and Screening Test opportunities ... is occurring using in vitro blood testing to ... impressive backing, has announced a single blood test ... faster than the market. New technology that definitively ...
(Date:12/6/2016)... 2016 Diabetes & Obesity Drug Development Pipeline ... disease cluster is currently dominated by therapeutics indicated for ... mellitus (T2DM), and the majority of the pipeline, in ... attributable to these indications. While products indicated for obesity ... are a large number of these products in the ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... Kenall Manufacturing, a leader in sealed healthcare ... The MPCNGX is a multi-function, sealed, LED luminaire that meets the needs of everyone ... when it’s needed. , A 2’ x 4’ model features four modes: ...
(Date:12/7/2016)... ... December 07, 2016 , ... OC87 Recovery Diaries ... schizophrenic mother in a unique, personal perspective through animation. , That woman ... addictive disorders at her private psychotherapy practice. Sheri’s mother, Pearl, lived with schizophrenia. ...
(Date:12/7/2016)... ... 2016 , ... Castle Dermatology Institute is now offering liquid facelifts with ... appearance to the face. Dr. Peyman Ghasri and Dr. Pedram Ghasri, San Fernando ... to rejuvenate and renew the facial appearance. , Sculptra is a highly effective ...
(Date:12/7/2016)... ... 07, 2016 , ... When it came time to blow out his candles on his 14th ... Pediatric Heart Transplant team at Joe DiMaggio Children’s Hospital surprised his family with ... 30th heart transplant recipient. , “He was playing at home, when we got the ...
(Date:12/7/2016)... TX (PRWEB) , ... December 07, 2016 , ... ... offering insurance and financial planning services to families and business owners in the ... funds on behalf of the Dallas Fallen Officer Foundation. , Established in 2009 ...
Breaking Medicine News(10 mins):